Voorham, JacoXu, XiaoPrice, David B.Golam, SarowarDavis, JillZhi Jie Ling, JoannaKerkhof, MarjanOw, MandyTran, Trung N.2018-12-122018-12-122019-02Voorham, J, Xu, X, Price, D B, Golam, S, Davis, J, Zhi Jie Ling, J, Kerkhof, M, Ow, M & Tran, T N 2019, 'Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma', Allergy, vol. 74, no. 2, pp. 273-283. https://doi.org/10.1111/all.135560105-4538RIS: urn:58911B552FDD5DF441E4FC2A0CC8CE01Mendeley: 6a6b662b-829d-3a54-a9ed-141b96ff4e9bhttp://hdl.handle.net/2164/11606Editorial support was provided by Mike Jaqua, PhD, and AlanSaltzman, PhD, of JK Associates, Inc., and Michael A. Nissen, ELS, ofAstraZeneca. This support was funded by AstraZeneca.11735671engSDG 3 - Good Health and Well-beingadverse outcomesasthmahealthcare costshealthcare resource utilizationsystemic corticosteroidsR Medicine (General)Supplementary DataR1Journal article10.1111/all.13556http://www.mendeley.com/research/healthcare-resource-utilization-costs-associated-incremental-systemic-corticosteroid-exposure-asthma742